Review



anti abcg1  (Novus Biologicals)


Bioz Verified Symbol Novus Biologicals is a verified supplier
Bioz Manufacturer Symbol Novus Biologicals manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    Novus Biologicals anti abcg1
    Anti Abcg1, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 94/100, based on 27 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/abcg1/ABCG1+Antibody/pm41898701-387-61-62
    Average 94 stars, based on 27 article reviews
    anti abcg1 - by Bioz Stars, 2026-09
    94/100 stars

    Images

    Related Articles

    Incubation:

    Article Title: Imeglimin Inhibits Macrophage Foam Cell Formation and Atherosclerosis in Streptozotocin-Induced Diabetic ApoE-Deficient Mice.
    Article Snippet: Equal amounts of protein (20 μg) were loaded onto NuPAGETM 4–12% Bis-Tris gradient gels (NOVEX by Life Technologies, Winston-Salem, NC, USA) and electrophoresed before being transferred onto nitrocellulose membranes. .. Membranes were blocked using 5% bovine serum albumin at room temperature for 1 h, followed by overnight incubation at 4 ◦C with primary antibodies targeting CD36 (PA1-16813, 1:1000, Thermo Fisher Scientific), ABCA1 (NB400-105, 1:1000, Novus Biologicals, Littleton, CO, USA), ABCG1 (NB400-132, 1:1000, Novus Biologicals), AMPK (2532, 1:1000, Cell Signaling Technology), phosphorylated AMPK (pAMPK, 2535, 1:1000, Cell Signaling Technology), and β-actin (ab8227, 1:10,000, Abcam, Cambridge, UK). .. After washing, membranes were incubated with horseradish peroxidase-conjugated secondary antibodies at room temperature for 1 h. Protein bands were visualized using an enhanced chemiluminescence (ECL) detection reagent (Thermo Fisher Scientific) and quantified using ImageJ software (version 1.53g, NIH, Bethesda, MD, USA).

    Article Title: Luteolin Nanomedicine with Stimulus-Driven Traceless Release for Targeting Treatment of Atherosclerosis by Enhancing Lipid Efflux
    Article Snippet: .. The membranes were blocked with 5% bovine serum albumin (BSA) in PBS for 1 h at room temperature and subsequently incubated overnight at 4 °C with specific primary antibodies, such as ABCA1 (Novus, USA) and ABCG1 (Novus, USA). ..

    Article Title: Ex Vivo Characterization of Peritoneal Macrophages from Novel ABCA1-LSL and ABCG1-LSL Mice for Macrophage-Specific ABC-Transporter Overexpression
    Article Snippet: We calculated the protein concentrations [ ] in PM lysates with a BCA assay (BioVision, Milpitas, CA, USA), and we loaded an equal mass of protein (1 μg) from lysates onto SDS-PAGE gels that were used for protein separation. .. We then transferred separated proteins onto PVDF membranes (Merck Millipore, Burlington, MA, USA), incubated the PVDF membranes in blocking buffer [ ], and then probed for either ABCA1 (1:500 dilution, sc-58219; Santa Cruz Biotechnology, Dallas, TX, USA) or ABCG1 (1:2000 dilution, NB400–132; Novus Biologicals, Littleton, CO, USA). .. Loading controls for our immunoblots included the housekeeping proteins GAPDH (1:750 dilution, sc-365062; Santa Cruz Biotechnology) and HSP90 (1:2500 dilution, 610419; BD Biosciences, San Jose, CA, USA).

    Article Title: Imeglimin Inhibits Macrophage Foam Cell Formation and Atherosclerosis in Streptozotocin-Induced Diabetic ApoE-Deficient Mice
    Article Snippet: Equal amounts of protein (20 μg) were loaded onto NuPAGETM 4–12% Bis-Tris gradient gels (NOVEX by Life Technologies, Winston-Salem, NC, USA) and electrophoresed before being transferred onto nitrocellulose membranes. .. Membranes were blocked using 5% bovine serum albumin at room temperature for 1 h, followed by overnight incubation at 4 °C with primary antibodies targeting CD36 (PA1-16813, 1:1000, Thermo Fisher Scientific), ABCA1 (NB400-105, 1:1000, Novus Biologicals, Littleton, CO, USA), ABCG1 (NB400-132, 1:1000, Novus Biologicals), AMPK (2532, 1:1000, Cell Signaling Technology), phosphorylated AMPK (pAMPK, 2535, 1:1000, Cell Signaling Technology), and β-actin (ab8227, 1:10,000, Abcam, Cambridge, UK). .. After washing, membranes were incubated with horseradish peroxidase-conjugated secondary antibodies at room temperature for 1 h. Protein bands were visualized using an enhanced chemiluminescence (ECL) detection reagent (Thermo Fisher Scientific) and quantified using ImageJ software (version 1.53g, NIH, Bethesda, MD, USA).

    Article Title: The Regulation of COX-2, ABCA1 and ABCG1 by the lncRNA PACERR links the inflammatory response and cholesterol homeostasis
    Article Snippet: Protein was extracted in RIPA buffer (Cell Signaling) with protease and phosphatase inhibitors (Roche) and subsequently normalized with a Pierce BCA Protein Assay Kit (Thermo Fisher Scientific). .. Samples (30 μg per well) were electrophoresed on 4–20% TGX-gradient gels (Bio-Rad Laboratories) and transferred to nitrocellulose membranes at 125 V for 2 h. Membranes were incubated overnight with the specified antibodies directed against COX-2 (Cayman 160106) ABCA1 (Novus Biologicals, NB400-105), ABCG1 (Novus NB400-132) and ß-actin (Sigma A5441). .. Proteins were visualized by using appropriate secondary antibodies and scanned with an Odyssey Imaging System (Li-Cor Biosciences).

    Western Blot:

    Article Title: Targeting the ARF6-dependent recycling pathway to alter lipid rafts and reduce inflammation.
    Article Snippet: .. Semi-quantitative analysis of western blots was performed by densitometry and presented as a proportion of control after normalization to loading controls .Antibodies used in western blot analysis: ABCA1 (Abcam, #ab18180, 1:3000), ATPase (Abcam, #ab76671, 1:5000), GAPDH (Merck, #CB1001, 1:5000), Arf6 (SigmaAldrich, #A5230, 1:2000), Cdc42(BD transduction Laboratories, #610929, 1:500), Erk1/2 (Millipore, #66192, 1:10000), pErk1/2 (Cell Signaling Tech.#4370, 1:2000), TMS1(Cell Signaling Jo urn al Pr e-p roo f 11 Tech.#67824 1:1000), NRLP3 (Cell Signaling Tech.#15101, 1:1000), Caspase-1 ((Cell Signaling Tech.#24232, 1:1000), ABCG1 (Novus Biol.#NB400-132, 1:1000), Anti-mouse HRP-linked antibody (Cell Signaling Tech.#7076, 1:5000), Anti-rabbit HRP-linked antibody (Cell Signaling Tech.#7074, 1:5000), .. To silence Cdc42 or Arf6 in RAW264.7 cells On -TARGETplus control siRNA (#D-001810), On -TARGETplus Cdc42 siRNA (#J-043087-09) or On -TARGETplus Arf6 siRNA(#J-04321709)Dharmacon) were transfected into cells using Lipofectamine RNAiMAX (Invitrogen #13778030)) according to manufacture protocol.

    Control:

    Article Title: Targeting the ARF6-dependent recycling pathway to alter lipid rafts and reduce inflammation.
    Article Snippet: .. Semi-quantitative analysis of western blots was performed by densitometry and presented as a proportion of control after normalization to loading controls .Antibodies used in western blot analysis: ABCA1 (Abcam, #ab18180, 1:3000), ATPase (Abcam, #ab76671, 1:5000), GAPDH (Merck, #CB1001, 1:5000), Arf6 (SigmaAldrich, #A5230, 1:2000), Cdc42(BD transduction Laboratories, #610929, 1:500), Erk1/2 (Millipore, #66192, 1:10000), pErk1/2 (Cell Signaling Tech.#4370, 1:2000), TMS1(Cell Signaling Jo urn al Pr e-p roo f 11 Tech.#67824 1:1000), NRLP3 (Cell Signaling Tech.#15101, 1:1000), Caspase-1 ((Cell Signaling Tech.#24232, 1:1000), ABCG1 (Novus Biol.#NB400-132, 1:1000), Anti-mouse HRP-linked antibody (Cell Signaling Tech.#7076, 1:5000), Anti-rabbit HRP-linked antibody (Cell Signaling Tech.#7074, 1:5000), .. To silence Cdc42 or Arf6 in RAW264.7 cells On -TARGETplus control siRNA (#D-001810), On -TARGETplus Cdc42 siRNA (#J-043087-09) or On -TARGETplus Arf6 siRNA(#J-04321709)Dharmacon) were transfected into cells using Lipofectamine RNAiMAX (Invitrogen #13778030)) according to manufacture protocol.

    Transduction:

    Article Title: Targeting the ARF6-dependent recycling pathway to alter lipid rafts and reduce inflammation.
    Article Snippet: .. Semi-quantitative analysis of western blots was performed by densitometry and presented as a proportion of control after normalization to loading controls .Antibodies used in western blot analysis: ABCA1 (Abcam, #ab18180, 1:3000), ATPase (Abcam, #ab76671, 1:5000), GAPDH (Merck, #CB1001, 1:5000), Arf6 (SigmaAldrich, #A5230, 1:2000), Cdc42(BD transduction Laboratories, #610929, 1:500), Erk1/2 (Millipore, #66192, 1:10000), pErk1/2 (Cell Signaling Tech.#4370, 1:2000), TMS1(Cell Signaling Jo urn al Pr e-p roo f 11 Tech.#67824 1:1000), NRLP3 (Cell Signaling Tech.#15101, 1:1000), Caspase-1 ((Cell Signaling Tech.#24232, 1:1000), ABCG1 (Novus Biol.#NB400-132, 1:1000), Anti-mouse HRP-linked antibody (Cell Signaling Tech.#7076, 1:5000), Anti-rabbit HRP-linked antibody (Cell Signaling Tech.#7074, 1:5000), .. To silence Cdc42 or Arf6 in RAW264.7 cells On -TARGETplus control siRNA (#D-001810), On -TARGETplus Cdc42 siRNA (#J-043087-09) or On -TARGETplus Arf6 siRNA(#J-04321709)Dharmacon) were transfected into cells using Lipofectamine RNAiMAX (Invitrogen #13778030)) according to manufacture protocol.

    Blocking Assay:

    Article Title: Ex Vivo Characterization of Peritoneal Macrophages from Novel ABCA1-LSL and ABCG1-LSL Mice for Macrophage-Specific ABC-Transporter Overexpression
    Article Snippet: We calculated the protein concentrations [ ] in PM lysates with a BCA assay (BioVision, Milpitas, CA, USA), and we loaded an equal mass of protein (1 μg) from lysates onto SDS-PAGE gels that were used for protein separation. .. We then transferred separated proteins onto PVDF membranes (Merck Millipore, Burlington, MA, USA), incubated the PVDF membranes in blocking buffer [ ], and then probed for either ABCA1 (1:500 dilution, sc-58219; Santa Cruz Biotechnology, Dallas, TX, USA) or ABCG1 (1:2000 dilution, NB400–132; Novus Biologicals, Littleton, CO, USA). .. Loading controls for our immunoblots included the housekeeping proteins GAPDH (1:750 dilution, sc-365062; Santa Cruz Biotechnology) and HSP90 (1:2500 dilution, 610419; BD Biosciences, San Jose, CA, USA).



    Similar Products

    97
    Thermo Fisher gene exp abcg1 mm00437390 m1
    Gene Exp Abcg1 Mm00437390 M1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/abcg1/Gene+Exp%2E+Abcg1%2C+Mm00437390_m1/bio_rxiv__64898__2026__03__04__709622-157-32--1
    Average 97 stars, based on 1 article reviews
    gene exp abcg1 mm00437390 m1 - by Bioz Stars, 2026-09
    97/100 stars
      Buy from Supplier

    95
    Proteintech abcg1
    Schematic of the anti-atherosclerotic mechanism of OPN-HMCN@MLT. ( A ) The study commenced with the synthesis of mesoporous carbon nanospheres (MCN) functionalized with an OPN-binding peptide and hyaluronic acid to construct the OPN-HMCN nanoplatform. The OPN-binding peptide was designed to recognize OPN enriched in the extracellular matrix and on the surface of foam cells, thereby enabling selective accumulation in OPN-rich pathological regions. Following OPN recognition, OPN-HMCN@MLT undergoes CD44-dependent endocytosis. Melatonin (MLT), a lipid autophagy–promoting agent, was subsequently encapsulated within the nanocarrier to form OPN-HMCN@MLT. Firstly, the released MLT can bind to and upregulate the expression of PPARα and PPARγ, which then promote the expression of downstream genes (ABCA1, <t>ABCG1,</t> ACOX-1, and CTP1A) and trigger the lipophagy. ( B ) Subsequently, its lipophagy-enhancing effects, including ABCA1/G1-mediated cholesterol efflux and CTP1A/ACOX-1-mediated mitochondrial fatty acid oxidation, were studied to confirm the reversal of foam cell formation. ( C ) These effects eventually promote foam cells to reverse into macrophages. Abbreviations: MCN, mesoporous carbon nanoparticle; OPN, osteopontin; MLT, melatonin; LDL, low-density lipoprotein; ox-LDL, oxidized low-density lipoprotein; PA, Photoacoustic.
    Abcg1, supplied by Proteintech, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/abcg1/ABCG1+Antibody/pmc12969391-127-27-37
    Average 95 stars, based on 1 article reviews
    abcg1 - by Bioz Stars, 2026-09
    95/100 stars
      Buy from Supplier

    86
    Deltagen Inc abca1 abcg1 dko deltagen inc n a mouse
    Schematic of the anti-atherosclerotic mechanism of OPN-HMCN@MLT. ( A ) The study commenced with the synthesis of mesoporous carbon nanospheres (MCN) functionalized with an OPN-binding peptide and hyaluronic acid to construct the OPN-HMCN nanoplatform. The OPN-binding peptide was designed to recognize OPN enriched in the extracellular matrix and on the surface of foam cells, thereby enabling selective accumulation in OPN-rich pathological regions. Following OPN recognition, OPN-HMCN@MLT undergoes CD44-dependent endocytosis. Melatonin (MLT), a lipid autophagy–promoting agent, was subsequently encapsulated within the nanocarrier to form OPN-HMCN@MLT. Firstly, the released MLT can bind to and upregulate the expression of PPARα and PPARγ, which then promote the expression of downstream genes (ABCA1, <t>ABCG1,</t> ACOX-1, and CTP1A) and trigger the lipophagy. ( B ) Subsequently, its lipophagy-enhancing effects, including ABCA1/G1-mediated cholesterol efflux and CTP1A/ACOX-1-mediated mitochondrial fatty acid oxidation, were studied to confirm the reversal of foam cell formation. ( C ) These effects eventually promote foam cells to reverse into macrophages. Abbreviations: MCN, mesoporous carbon nanoparticle; OPN, osteopontin; MLT, melatonin; LDL, low-density lipoprotein; ox-LDL, oxidized low-density lipoprotein; PA, Photoacoustic.
    Abca1 Abcg1 Dko Deltagen Inc N A Mouse, supplied by Deltagen Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/abcg1/a+abca1+abcg1+deltagen+dko+inc+mouse+n/pm41926284-190-121-123
    Average 86 stars, based on 1 article reviews
    abca1 abcg1 dko deltagen inc n a mouse - by Bioz Stars, 2026-09
    86/100 stars
      Buy from Supplier

    94
    Novus Biologicals anti abcg1
    Schematic of the anti-atherosclerotic mechanism of OPN-HMCN@MLT. ( A ) The study commenced with the synthesis of mesoporous carbon nanospheres (MCN) functionalized with an OPN-binding peptide and hyaluronic acid to construct the OPN-HMCN nanoplatform. The OPN-binding peptide was designed to recognize OPN enriched in the extracellular matrix and on the surface of foam cells, thereby enabling selective accumulation in OPN-rich pathological regions. Following OPN recognition, OPN-HMCN@MLT undergoes CD44-dependent endocytosis. Melatonin (MLT), a lipid autophagy–promoting agent, was subsequently encapsulated within the nanocarrier to form OPN-HMCN@MLT. Firstly, the released MLT can bind to and upregulate the expression of PPARα and PPARγ, which then promote the expression of downstream genes (ABCA1, <t>ABCG1,</t> ACOX-1, and CTP1A) and trigger the lipophagy. ( B ) Subsequently, its lipophagy-enhancing effects, including ABCA1/G1-mediated cholesterol efflux and CTP1A/ACOX-1-mediated mitochondrial fatty acid oxidation, were studied to confirm the reversal of foam cell formation. ( C ) These effects eventually promote foam cells to reverse into macrophages. Abbreviations: MCN, mesoporous carbon nanoparticle; OPN, osteopontin; MLT, melatonin; LDL, low-density lipoprotein; ox-LDL, oxidized low-density lipoprotein; PA, Photoacoustic.
    Anti Abcg1, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/abcg1/ABCG1+Antibody/pm41898701-387-61-62
    Average 94 stars, based on 1 article reviews
    anti abcg1 - by Bioz Stars, 2026-09
    94/100 stars
      Buy from Supplier

    95
    Proteintech erk
    Schematic of the anti-atherosclerotic mechanism of OPN-HMCN@MLT. ( A ) The study commenced with the synthesis of mesoporous carbon nanospheres (MCN) functionalized with an OPN-binding peptide and hyaluronic acid to construct the OPN-HMCN nanoplatform. The OPN-binding peptide was designed to recognize OPN enriched in the extracellular matrix and on the surface of foam cells, thereby enabling selective accumulation in OPN-rich pathological regions. Following OPN recognition, OPN-HMCN@MLT undergoes CD44-dependent endocytosis. Melatonin (MLT), a lipid autophagy–promoting agent, was subsequently encapsulated within the nanocarrier to form OPN-HMCN@MLT. Firstly, the released MLT can bind to and upregulate the expression of PPARα and PPARγ, which then promote the expression of downstream genes (ABCA1, <t>ABCG1,</t> ACOX-1, and CTP1A) and trigger the lipophagy. ( B ) Subsequently, its lipophagy-enhancing effects, including ABCA1/G1-mediated cholesterol efflux and CTP1A/ACOX-1-mediated mitochondrial fatty acid oxidation, were studied to confirm the reversal of foam cell formation. ( C ) These effects eventually promote foam cells to reverse into macrophages. Abbreviations: MCN, mesoporous carbon nanoparticle; OPN, osteopontin; MLT, melatonin; LDL, low-density lipoprotein; ox-LDL, oxidized low-density lipoprotein; PA, Photoacoustic.
    Erk, supplied by Proteintech, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/abcg1/ABCG1+Antibody/pm41800476-80-37-41
    Average 95 stars, based on 1 article reviews
    erk - by Bioz Stars, 2026-09
    95/100 stars
      Buy from Supplier

    95
    Proteintech ap proteintech
    Schematic of the anti-atherosclerotic mechanism of OPN-HMCN@MLT. ( A ) The study commenced with the synthesis of mesoporous carbon nanospheres (MCN) functionalized with an OPN-binding peptide and hyaluronic acid to construct the OPN-HMCN nanoplatform. The OPN-binding peptide was designed to recognize OPN enriched in the extracellular matrix and on the surface of foam cells, thereby enabling selective accumulation in OPN-rich pathological regions. Following OPN recognition, OPN-HMCN@MLT undergoes CD44-dependent endocytosis. Melatonin (MLT), a lipid autophagy–promoting agent, was subsequently encapsulated within the nanocarrier to form OPN-HMCN@MLT. Firstly, the released MLT can bind to and upregulate the expression of PPARα and PPARγ, which then promote the expression of downstream genes (ABCA1, <t>ABCG1,</t> ACOX-1, and CTP1A) and trigger the lipophagy. ( B ) Subsequently, its lipophagy-enhancing effects, including ABCA1/G1-mediated cholesterol efflux and CTP1A/ACOX-1-mediated mitochondrial fatty acid oxidation, were studied to confirm the reversal of foam cell formation. ( C ) These effects eventually promote foam cells to reverse into macrophages. Abbreviations: MCN, mesoporous carbon nanoparticle; OPN, osteopontin; MLT, melatonin; LDL, low-density lipoprotein; ox-LDL, oxidized low-density lipoprotein; PA, Photoacoustic.
    Ap Proteintech, supplied by Proteintech, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/abcg1/ABCG1+Antibody/pm41800476-80-34-35
    Average 95 stars, based on 1 article reviews
    ap proteintech - by Bioz Stars, 2026-09
    95/100 stars
      Buy from Supplier

    Image Search Results


    Schematic of the anti-atherosclerotic mechanism of OPN-HMCN@MLT. ( A ) The study commenced with the synthesis of mesoporous carbon nanospheres (MCN) functionalized with an OPN-binding peptide and hyaluronic acid to construct the OPN-HMCN nanoplatform. The OPN-binding peptide was designed to recognize OPN enriched in the extracellular matrix and on the surface of foam cells, thereby enabling selective accumulation in OPN-rich pathological regions. Following OPN recognition, OPN-HMCN@MLT undergoes CD44-dependent endocytosis. Melatonin (MLT), a lipid autophagy–promoting agent, was subsequently encapsulated within the nanocarrier to form OPN-HMCN@MLT. Firstly, the released MLT can bind to and upregulate the expression of PPARα and PPARγ, which then promote the expression of downstream genes (ABCA1, ABCG1, ACOX-1, and CTP1A) and trigger the lipophagy. ( B ) Subsequently, its lipophagy-enhancing effects, including ABCA1/G1-mediated cholesterol efflux and CTP1A/ACOX-1-mediated mitochondrial fatty acid oxidation, were studied to confirm the reversal of foam cell formation. ( C ) These effects eventually promote foam cells to reverse into macrophages. Abbreviations: MCN, mesoporous carbon nanoparticle; OPN, osteopontin; MLT, melatonin; LDL, low-density lipoprotein; ox-LDL, oxidized low-density lipoprotein; PA, Photoacoustic.

    Journal: Bioactive Materials

    Article Title: A foam cell-targeted lipophagy restoration strategy stabilizes vulnerable atherosclerotic plaques

    doi: 10.1016/j.bioactmat.2026.02.041

    Figure Lengend Snippet: Schematic of the anti-atherosclerotic mechanism of OPN-HMCN@MLT. ( A ) The study commenced with the synthesis of mesoporous carbon nanospheres (MCN) functionalized with an OPN-binding peptide and hyaluronic acid to construct the OPN-HMCN nanoplatform. The OPN-binding peptide was designed to recognize OPN enriched in the extracellular matrix and on the surface of foam cells, thereby enabling selective accumulation in OPN-rich pathological regions. Following OPN recognition, OPN-HMCN@MLT undergoes CD44-dependent endocytosis. Melatonin (MLT), a lipid autophagy–promoting agent, was subsequently encapsulated within the nanocarrier to form OPN-HMCN@MLT. Firstly, the released MLT can bind to and upregulate the expression of PPARα and PPARγ, which then promote the expression of downstream genes (ABCA1, ABCG1, ACOX-1, and CTP1A) and trigger the lipophagy. ( B ) Subsequently, its lipophagy-enhancing effects, including ABCA1/G1-mediated cholesterol efflux and CTP1A/ACOX-1-mediated mitochondrial fatty acid oxidation, were studied to confirm the reversal of foam cell formation. ( C ) These effects eventually promote foam cells to reverse into macrophages. Abbreviations: MCN, mesoporous carbon nanoparticle; OPN, osteopontin; MLT, melatonin; LDL, low-density lipoprotein; ox-LDL, oxidized low-density lipoprotein; PA, Photoacoustic.

    Article Snippet: To block nonspecific binding, membranes were incubated with 5% skim milk for 1 h. Thereafter, membranes were incubated overnight at 4 °C with primary antibodies against ABCA1, ABCG1, ACOX1, CPT1A, LC3 (ab192890, 1:2000, abcam), LAMP1 (84658-5-RR, 1:8000, Proteintech), PPARα (66826-1-Ig, 1:3000, Proteintech), PPARγ (66936-1-Ig, 1:10000, Proteintech), P62 (18420-1-AP, 1:10000, Proteintech), MCAD (55210-1-AP, 1:3000, Proteintech), LCAD (17526-1-AP, 1:10000, Proteintech), tubulin (80762-1-RR, 1:10000, Proteintech), GAPDH (60004-1-Ig, 1:50000, Proteintech), and β-actin (66009-1-Ig, 1:20000, Proteintech).

    Techniques: Binding Assay, Construct, Expressing